Donate
Friends of VIDO
Donor Roll
Donor News
Why Donate?
About
History
Mission, Vision, Values
Safety & Security
Community Liaison Committee
Annual Reports
Contact
Team
Board of Directors
Senior Leadership
Science Management
Principal Scientists and Veterinarians
Scientific Advisory Board
Access Committee
Research
Contract Research
Bacterial Vaccine Development
Viral Vaccine Development
Vaccine Formulation & Delivery
Veterinary Services
Patents
Publications
Facilities
Vaccine Development Centre
Accessing InterVac
Careers
Current Opportunities
Training
Visiting Scientists
Living in Saskatoon
VIDO Post Doctoral Association
News
Minister Champagne highlights USask’s VIDO in post-budget tour
VIDO scientists receive CIHR funding to support research on high impact infectious diseases
VIDO’s first Animal Health Summit brings animal health stakeholders together to prepare for foot and mouth disease
VIDO led technology a key part of the vaccine protecting koalas from chlamydia
VIDO scientists strengthen mpox preparedness
VIDO and Pirbright expand collaboration to advance vaccine manufacturing
USask’s VIDO selected for CEPI’s international research network
VIDO receives significant CIHR support for research into emerging coronaviruses
VIDO awarded U.S. contract for its Vaccine Development Centre
VIDO awarded >$1million to develop innovative solutions for Saskatchewan’s agriculture industry
USask’s VIDO selected to join DIANA innovation accelerator
CEPI awards USask’s VIDO $6M for vaccine development
New funding will help predict SARS-CoV-2 variants and protect vulnerable populations
Saskatoon hospital foundations offer support to USask’s VIDO
New VIDO Vaccine Development Centre supports vaccine innovation protecting Canadians, animals
New support for VIDO as a research facility of national importance
New $8.1 million funding for VIDO will protect Canadians and our animals from high consequence pathogens
VIDO’s economic impact over half a billion dollars: SREDA study
VIDO first non-U.S. organization invited to join high containment network
CIHR supports research targeting high impact infectious diseases
Integrating field and laboratory studies to better predict the next emerging zoonotic pathogen
The avian influenza outbreak: what you need to know
VIDO partners with four research hubs to strengthen Canada’s infectious disease preparedness
VIDO scientists receive leadership awards for excellence in vaccine research
VIDO and VFI collaborate to strengthen pandemic preparedness
Saskatchewan Blue Cross invests $150K to help establish USask’s VIDO as Canada’s Centre for Pandemic Research
VIDO awarded over a million dollars for innovative research projects
USask’s VIDO announces positive Phase 1 results for COVAC-2
VIDO research provides insight into the immune response and possible long-term health impacts associated with COVID-19
Infectious disease research bolstered by Hospitals of Regina Foundation
Saskatoon couple donates $1 million to VIDO to enhance ground-breaking vaccine research
AnGes Collaborates with University of Saskatchewan’s VIDO-InterVac to Develop Ebola Polyclonal Antibody Therapy Using DNA Vaccine Technology
Canadian universities partner to fight COVID-19 at USask’s VIDO-InterVac
Director Andrew Potter's Blog: Why skipping the flu shot is a selfish gamble
USask statement on 2024-25 federal budget
USask awarded $1.7 million for “high-risk, high-reward” research projects
Investments in USask livestock research fuels innovation, protects animal health
Developing oral vaccine for chronic wasting disease goal of funding research
A new opportunity to develop livestock and human vaccine in Saskatchewan: SARM supports VIDO‘s effort to strengthen the response to infectious disease
USask hosts the Prime Minister of Canada
VIDO: Advancing human, animal health at home and abroad
VIDO: Saskatchewan’s gift to global health
CEPI: The Race to Future-Proof Coronavirus Vaccines
Researchers’ study of Salmonella transmission first of its kind
New funding to advance Canada’s beef sector
Individual donors vital for VIDO to become Canada’s Centre for Pandemic Research
VIDO part of western Canadian team developing tools to stop chronic wasting disease
Research team aims to develop vaccines for prion diseases
Canada needs to plan for inevitable future pandemics
Leaders in discovery: five USask researchers honoured with top provincial health awards
USask researchers seek to prevent liver disease, high blood pressure, and understand lifelong impacts of Zika virus
Sask.-based research offers hope in unsettling times
Three USask researchers become fellows in the Canadian Academy of Health Sciences
Prime Minister announces new support for COVID-19 medical research and vaccine development
USask VIDO-InterVac awarded $23M for COVID-19 vaccine research
ZYUS Collaborates with USask’s VIDO-InterVac to Develop a Plant-Based Vaccine for COVID-19
A first hand ebola experience
Ebola concern on the rise for Canadians
Worry more about getting flu shot, not Ebola: VIDO
VIDO-InterVac 2013-2014 Annual Report released
Canada and China expand collaboration in health education and research
Researcher hunts for faster gonorrhea test
VIDO-InterVac Director featured on Canada Am
VIDO-InterVac attains ISO 9001:2008 certification
VIDO-InterVac PhD student wins best poster award
VIDO celebrates certification of the International Vaccine Centre at the University of Saskatchewan
PREVENT and VIDO sign collaborative agreement with South China United Vaccine Institute and Guangzho Institute of Respiratory Disease
VIDO-InterVac scientists receive $1M in Agricuture Funding
Former VIDO Director Lorne Babiuk inducted into Saskatchewan Agriculture Hall of Fame
Young Innovators - Researcher hunts for hepatitis C cure
VIDO-InterVac researchers address cattle disease and food security in Kenya
VIDO-InterVac Director interviewed by MacLeans: Fighting scary vaccine stories with scarier no-vaccine stories
Biotechnology Focus: InterVac - New opportunities in infectious disease research
Former VIDO-InterVac Director Dr. Lorne Babiuk honored with Gairdner Wightman Award
VIDO-InterVac scientists receive funding from Canadian Swine Health Board
VIDO-InterVac researcher receives CIHR Operating Grant
U of S VIDO-InterVac Joins National Launch of Canada’s new $100 bank note
U of S International Vaccine Centre Celebrates Grand Opening
VIDO-InterVac: Leading Vaccine Discovery
Andrew Potter Blog: Vaccine challenges and opportunities
VIDO-InterVac: Keeping Canada at forefront of discovery science
VIDO-InterVac Board Chair wins prestigious award
BIOTECanada Insights Feature: InterVac
Researchs at U of S VIDO-InterVac close in on vaccine to protect babies
U of S alumnus and tech helping in fight against Ebola
VIDO-InterVac at the U of S hosts international experts in human, animal health
VIDO-InterVac announces new Associate Director, Operations and Maintenance
VIDO-InterVac signs exclusive license agreement for developing a novel vaccine against Respiratory Syncytial Virus
VIDO-InterVac at U of S signs exclusive license agreement for developing a vaccine against Chronic Wasting Disease
The VIDO Swine Technical Group discusses swine production
VIDO-InterVac Scientist named new Jarislowsky Chair in Biotechnology
Publication: VIDO Beef Technical Group and Dr. Steven Hendrick
U of S student develops new E. coli vaccine
VIDO-InterVac Scientist Named New Canada Research Chair
VIDO-InterVac Major Partner in HIV/AIDS Vaccine Pilot Plant Bid
U of S VIDO Scientist develop revolutionary new research tool
Associate Director Paul Hodgson's Biotech Blog: An ounce of prevention
World's first cattle vaccine to reduce E. coli O157:H7 threat receives full licensing approval in Canada
More funds for infectious disease research, vaccine development
Saskatchewan delegation to attend biotech conference
VIDO launches $2-million project with India to develop tools for improved food safety
VIDO team awarded $445,000 from PrioNet Canada for BSE vaccine
VIDO scientist receives $620,000 to tackle respiratory disease
Pan-Provincial Vaccine Enterprise (PREVENT) announces board members, vaccine targets
VIDO awarded $2.4 million for vaccine coverage tailored to Saskatchewan's needs
VIDO scientist receives university teaching excellence award
VIDO key stakeholder in Centre of Excellence for Commercialization and Research
InterVac weathers market pressure and wins final approval
Sod-Turning Celebration Launches U of S International Vaccine Centre
New Associate Director of Research Named
Saskatoon is building success in vaccine research
New VIDO Director Named
Community Liaison Committee Launched for U of S InterVac
Colorado State University to confer honorary degree on VIDO director
Government of Saskatchewan commits $24.7 million to InterVac
VIDO Director accepts new position at University of Alberta
Groundbreaking vaccine co-developed by U of S VIDO approved to protect water and food supply from E.coli O157:H7 contamination
Bioniche E. coli O157:H7 Cattle Vaccine Authorized for Field Use in Canada
U of S VIDO team discovers key step in flu virus replication
International Centre for Infectious Diseases Names New Board Chair
Maternal Immunization May Protect Newborns from Whooping Cough U of S VIDO Study
Lorne Babiuk invested into Order of Canada
Dr. Paul Hodgson joins VIDO as Associate Director of Business Development
U of S Researchers Develop New Vaccine Candidate Against Hepatitis C
Lorne Babiuk receives SHRF Achievement Award (Biomedical Research)
VIDO Director named Officer of the Order of Canada
New $24 million InterVac funding to benefit Canadian livestock industry
City of Saskatoon Invests $250,000 in International Vaccine Centre
VIDO Awarded $4 M for Industrial Research Chairs in Food Safety
VIDO to headquarter $61.8 million International Vaccine Centre
VIDO Tech Report: VIDO-developed SARS vaccine candidates fast-tracked to testing
VIDO Tech Report: Horse knowledge helps researchers solve cross-species diseases
$19.2 Million Awarded to U of S to Help Build International Vaccine Centre
VIDO Tech Report: VIDO uses livestock expertise to tackle whooping cough in humans
U of S and Partners Celebrate Grand Opening of $17.8 M VIDO Expansion
VIDO director receives Saskatchewan Order of Merit
New vaccine technology offers multi-benefits for livestock producers
VIDO Director honoured for lifetime commitment to animal health
VIDO name updated to Vaccine and Infectious Disease Organization
Platform technologies power a new generation of vaccines
VIDO targets world's first vaccine for Hepatitis C
Researchers test pig virus protein to produce vaccine
Funding announced for vaccine against CWD
New IDRC funding backs VIDO-InterVac research to benefit cattle producers in Kenya
Should you be getting your measles vaccine?
Unique collaboration will combat deadly disease found in pigs
Meat system safe despite BSE case
Funding announced to enhance influenza vaccine research and development
Associate director receives honorary diploma
Funding awarded to develop vaccines for bovine tuberculosis and Johne’s disease
VIDO-InterVac celebrates its 40th Anniversary today with release of 2014-2015 Annual Report
Line Blurs Between Animal and Human Health
Dr. Philip Griebel receives 2015 AAVI Distinguished Veterinary Immunologist Award
Young Innovators: U of S student works on cattle vaccine for 'lung plague'
UofS Expert Weighs on Zika Virus Outbreaks
Recent H1N1 virus outbreak
Zika virus travel warning
VIDO-InterVac Director cautions winter vacationers on CBC radio
VIDO-InterVac Develops Vaccine for Devastating Pig Virus
VIDO-InterVac Research Fellow Jo-Anne Dillon named to Royal Society of Canada
Former VIDO-InterVac Director wins World Agriculture Prize
VIDO-InterVac receives funding from the Saskatoon Poppy Fund to support students researching Tuberculosis
VIDO-InterVac awarded $19.3 million to advance innovation
VIDO-InterVac helping to fight Zika virus
Tackling infectious diseases: Canada’s role in the global effort
VIDO-InterVac to field test a bovine TB prototype vaccine in 2 years
Going viral
VIDO-InterVac releases 2016-2017 Annual Report
The search continues for TB and JD vaccines
VIDO-InterVac tackles infectious diseases in world-class facilities
Dr. Andrew Potter receives SHRF Achievement Award
Saskatoon researcher Dr. Andrew Potter honoured with lifetime achievement award
'A few infected people can really impact what goes on locally'
International Partnership Results in New Vaccine for Cattle in Africa
U of S gets major federal boost for isotope and vaccine production, water research
Federal investment helps bring vaccine manufacturing facility to Saskatoon
How a new vaccine could save cattle herds – and livelihoods
Six world-first vaccines among USask’s VIDO-InterVac contributions to global health
Volker Gerdts Named as New VIDO-InterVac Director and CEO
USask VIDO-InterVac expands international role to test antiviral compounds against COVID-19
Lung plague vaccine wins international award
Increasing Canada’s Preparedness for African swine fever with the University of Saskatchewan’s VIDO-InterVac
VIDO-InterVac approved to work on SARS-CoV-2
Extending the lifespan of N95 masks
New CT scanner gives USask’s VIDO-InterVac scientists a window on COVID-19 disease
VIDO’s COVID-19 vaccine receives Health Canada clinical trial approval
A new year, and a new look
USask’s VIDO begins COVID-19 vaccine clinical trials at CCfV
VIDO gains provincial support towards becoming a ‘Centre for Pandemic Research’
Canada’s Global Nexus and VIDO join forces to combat COVID–19
Federal budget supports USask’s VIDO with $59.2M
Young Innovators: U of S research team aims to develop salmonella vaccine
Young Innovators: Innovative research finds influenza detection system in body
Early research promising for new sheep respiratory vaccine
Agencies search for ASF vaccine
Using a new approach to create the first bovine tuberculosis vaccine
2018 STIC Award winners showcased during third annual event
Vaccine development speeding up
New CFI funding will foster long-term sustainability of two USask national research facilities
Dr. Andrew Potter receives 2019 Saskatchewan Order of Merit
Efforts to Create ASF Vaccines Result in Cautious Optimism
Reverse vaccinology approach for novel bovine tuberculosis vaccines: The Canadian ReVAMP project
Dr. Andy Potter among Saskatchewan Order of Merit recipients
TB in bison studied at LFCE and VIDO-InterVac
Canada needs small-scale vaccine manufacturing to support research, and help save human and animal lives
Novel vaccination approach enhances worker safety
U of Sask. could help prepare for outbreaks by producing human vaccines for Canada, centre director says
USask’s VIDO-InterVac and South Korean’s International Vaccine Institute to undertake scientific exchanges
Mild Zika infection in fetuses may cause brain abnormalities
Saskatchewan Funds Coronavirus Vaccine Research
Canadian scientists first to test novel diagnostic tool for TB in bison
Saskatchewan government invests $3.6M in USask COVID-19 vaccine research
VIDO-InterVac-led research team at USask awarded almost $1M to fight new coronavirus
Canada’s plan to mobilize science to fight COVID-19
PM announces $12M for new vaccine manufacturing at USask’s VIDO-InterVac, part of $23.3M for the lab to fight COVID-19 and other infectious disease threats
New Money Aids Saskatchewan’s Search For Covid-19 Vaccine
USask VIDO-InterVac and International Vaccine Institute collaborate on COVID-19 work
SHA and VIDO-InterVac partner to help ensure supply of N95 respiratory masks
USask’s VIDO-InterVac and the National Research Council of Canada collaborate to advance development of vaccine against COVID-19
Promising pre-clinical results for USask VIDO-InterVac COVID-19 vaccine
CFI awards $77.5M to help major USask science facilities address COVID-19 and other global challenges
VIDO-InterVac on track to become ‘Canada’s centre for pandemic research’
USask livestock research receives significant investment to advance industry
New support to produce COVID-19 vaccines and treatments in Canada
Ministers Champagne, Joly and Carr highlight Budget 2021 biomanufacturing investments
Alumni Ron and Jane Graham’s $5.9M gift assists vaccine research, Huskie Athletics, engineering and education students at USask
The University of the Sunshine Coast leads rollout of critical vaccine for koalas
Milan Obradovic
Head of Client Services
306-966-3372
milan.obradovic@usask.ca
